Village Green
Daily Intelligence Brief
Thursday, June 4, 2026 | 7:30 AM ET
Curated from social media posts and threads
DEA Registration Deadline: June 22 Hard Stop for Medical Operators
State-licensed medical cannabis operators have until June 22, 2026 to file federal DEA paperwork or lose protected operating status during review. The 60-day filing window closes after that date.
Iowa Doubles Dispensary Cap: Bipartisan Bill Expands Rural Access
Governor Kim Reynolds signed HF 990 into law, raising the state’s medical cannabis dispensary limit from 5 to 10 locations with near-unanimous bipartisan support. Also extends eligibility to out-of-state residents.
Connecticut Strips Labeling Transparency: Industry Lobbying Removes Radiation Disclosure
Connecticut’s cannabis industry stripped mandatory disclosure requirements from Public Act 26-8 before Governor Lamont signed it into law, replacing FDA-aligned labeling standards with generic signage.
Record M&A Quarter: $4.2B in Cannabis Deals Through 11 Weeks of 2026
Cannabis industry posts its biggest M&A quarter ever—$4.2 billion through early June, exceeding all of 2024 combined. Price compression forces consolidation as smaller operators face margin squeeze.
Schedule III Tax Relief: Section 280E Restrictions Lifted for Medical Businesses
Medical cannabis operators immediately eligible for tax deductions under Schedule III reclassification. Eliminates punishing 280E restrictions that previously made profitability difficult for smaller operators.
DEA Hearing Begins June 29: Final Stage of Recreational Rescheduling Review
DEA administrative hearing starts June 29, 2026 to decide whether recreational marijuana follows medical into Schedule III. Decision will set federal policy trajectory for next phase of legalization.
Pennsylvania Advances Hospital Cannabis Access Bill for Terminal Patients
Pennsylvania House passes legislation allowing terminal patients to access medical cannabis through hospital systems. Expands palliative care options and accelerates state’s regulated market integration.
NSW Aligns Drug Driving Rules with Medical Prescribing: Regulatory Alignment in AU
New South Wales moves to align drug-driving enforcement with medical cannabis prescription practice, reducing liability for patients legally using prescribed medications.
Wyld Acquires Grön: Strategic Consolidation Focuses on Brand Strength & Demand
Wyld’s acquisition of Grön signals consolidation wave moving toward disciplined phase focused on proven brand equity and customer demand rather than license accumulation.
Organigram Closes Sanity Group Acquisition: BAT & Debt Financing Secured
Organigram completes acquisition of Sanity Group with backing from British American Tobacco and secured credit facilities, signaling major operator confidence in 2026 market expansion.
Market Projection: U.S. Cannabis Retail Sales Target $47B in 2026
Industry analysis forecasts U.S. cannabis retail sales reaching nearly $47 billion in 2026, with some estimates exceeding $50B. Growth trajectory incentivizes consolidation among well-capitalized players.
Schedule III Compliance Alert: Hemp-Derived Product Deadline November 12, 2026
Separate federal definition change for hemp-derived products (delta-8, THCA) takes effect November 12, 2026. Operators must prepare compliance strategies for evolving cannabinoid regulations.
Published: Thursday, June 4, 2026 | 7:30 AM ET | Curated by Sheeba
Village Green intelligence briefing • Weedstock analytics